G

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Director – Global Commercial Learning Strategy & Curriculum

Instructional Design & Curriculum DevelopmentConfirmed live in the last 24 hours
Full-timeFoster City, CA, USA

About the Job

Requirements

  • Bachelor's degree and twelve years of experience, or Master's degree and ten years of experience, or PhD and eight years of experience.
  • Significant commercial learning, capability development, curriculum strategy, or instructional design experience within the pharmaceutical, biotechnology, healthcare, or another regulated industry.
  • Experience leading global or enterprise learning initiatives in a complex, matrixed organization.
  • Expertise in curriculum architecture, learner journey design, instructional design, and content governance.
  • Experience supporting Product and Therapeutic Area learning and partnering with Marketing and other commercial capability owners.
  • Ability to establish scalable strategies, standards, governance frameworks, and flexible operating models.
  • Proven ability to influence senior stakeholders and align teams across functions, regions, and affiliates.
  • Experience leading blended teams of employees, contractors, agencies, and external partners.
  • Working knowledge of regulated content development, localization, pharmaceutical content approval, and content lifecycle management.
  • Experience improving learning quality, speed, scalability, or impact through content reuse, automation, artificial intelligence, or new operating models.

Responsibilities

  • Define and evolve global commercial learning architecture, curriculum strategy, governance, and learner journeys across Product and Therapeutic Area learning, Sales Leader Development, Marketing Excellence, selling skills, and advanced commercial capabilities.
  • Translate business priorities into connected, scalable learning solutions that balance global consistency with local market needs.
  • Lead the instructional design function and establish standards for curriculum design, learner experience, content quality, and delivery.
  • Govern the commercial learning portfolio, including content lifecycle management, localization, pharmaceutical review, and reuse of learning assets and intellectual property.
  • Lead a flexible development model that leverages internal expertise, contractors, external partners, and artificial intelligence-enabled capabilities while preserving institutional knowledge.
  • Evaluate resourcing and investment trade-offs to optimize quality, speed, scalability, and business impact.
  • Serve as a strategic advisor and drive alignment across Global Commercial Learning & Development, Product and Therapeutic Area Learning, Marketing, global affiliates, and enabling functions.
  • Champion global learning solutions and incorporate affiliate and market insights into future curriculum and learner journey strategies.
  • Connect content and resources across functions to reduce duplication, break down silos, and accelerate development.
  • Partner with Learning Technology and Learning Effectiveness leaders to enable scalable, measurable, and artificial intelligence-enabled learning solutions.
  • Create inclusion by modeling inclusion and embedding the value of diversity in the management of teams.
  • Develop talent by understanding employees' skills, experience, aspirations, and potential; coaching them on current performance and future potential; and ensuring they receive feedback and insight to grow and develop.
  • Empower teams by aligning goals, purpose, and organizational objectives, holding employees accountable, removing barriers, and connecting the team to the broader organization.

About the Company

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Gilead Sciences is a biopharmaceutical company that discovers, develops and sells medicines for HIV, viral hepatitis and other liver diseases, cancer and inflammatory conditions. Its HIV business covers both treatment, led by the once-daily pill Biktarvy, and prevention, including Descovy and Yeztugo, a lenacapavir injection given twice a year. In cancer, its Kite unit makes CAR T-cell therapies from patients' own immune cells, and Trodelvy is an antibody-drug conjugate for breast cancer. Gilead earns revenue by selling its drugs to wholesalers, specialty pharmacies, hospitals and governments worldwide after regulatory approval. The company was founded in 1987 and is headquartered in Foster City, California.

Company size
10,001+
Company stage
IPO
Headquarters
Foster City, CA
Founded
1987

Recently Posted Jobs

Explore more opportunities at Gilead Sciences

See more jobs